JASPER THERAPEUTICS, INC. Effective Tax Rate
JASPER THERAPEUTICS, INC. (JSPR) reported Effective Tax Rate of -0.60% for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-05-24.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2021-05-24
- JASPER THERAPEUTICS, INC. effective income tax rate reconciliation, percent for fiscal 2020 was -0.60%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 5 month | Effective Income Tax Rate Reconciliation, Percent 5 month as first filed | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|---|---|
| 2020-12-31 | -0.60% 10-K/A · filed 2021-05-24 | -7.00% 10-K · filed 2021-03-30 | ||
| 2019-12-31 | -2.70% 10-K/A · filed 2021-05-24 | 88.80% 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |